Callan Family Office’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3M Sell
9,118
-451
-5% -$162K 0.07% 272
2025
Q4
$3.36M Buy
9,569
+1,419
+17% +$517K 0.07% 247
2025
Q3
$3.01M Sell
8,150
-642
-7% -$248K 0.1% 216
2025
Q2
$3.48M Buy
8,792
+4,655
+113% +$1.74M 0.11% 199
2025
Q1
$1.54M Sell
4,137
-269
-6% -$102K 0.12% 157
2024
Q4
$1.59M Buy
+4,406
New +$1.63M 0.1% 174

Other funds holding SYK

Callan Family Office's SYK Position: Q1 2026 in Review

Callan Family Office reduced its Stryker (SYK) stake by 4.7% in Q1 2026, selling an estimated $162K and leaving 9,118 shares worth $3M. The position accounts for 0.07% of the portfolio, ranked #272.

Callan Family Office first reported a position in SYK in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.48M in Q2 2025. 2,294 funds tracked by Wall St. Rank hold SYK as of Q1 2026.

  • Callan Family Office held 9,118 shares of Stryker worth $3M as of Q1 2026.
  • Callan Family Office sold 451 Stryker shares in Q1 2026, an estimated $162K.
  • Stryker made up 0.07% of Callan Family Office's portfolio in Q1 2026, its #272 holding.
  • Callan Family Office first reported a position in Stryker in Q4 2024 and has held it in 6 quarters since.
  • Callan Family Office's Stryker position peaked at $3.48M in Q2 2025.
  • 2,294 funds tracked by Wall St. Rank held Stryker as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.